Carolina 225

When Weaker is Better

Professor Sam Lai says this research will lead to greater protection from pathogens such as viruses and bacteria...

Professor Sam Lai says this research will lead to greater protection from pathogens such as viruses and bacteria...

Strong molecular bonds between antibodies and biological gels, such as mucus, aren’t necessary to catch pathogens as was previously thought. In fact, rapid, weak interactions between antibodies and biogels are better for locking down foreign invaders in the body’s first line of defense.

It’s like looking for a parking spot in a crowded lot, Sam Lai, Ph.D., an associate professor in the UNC Eshelman School of Pharmacy.  “If all the cars park for hours on average, then it is going to be very difficult for a new vehicle to find a spot. That’s strong binding,” he said. “But if each car is only parked for a minute or less, then you’ll have no trouble finding a spot.”

This research should ultimately lead to greater protection from pathogens such as viruses and bacteria. Lai’s work has spun off a company, Mucommune, which is working to engineer antibodies that can be applied topically to prevent diseases at the infection site.

Read the complete Carolina Story from the UNC Eshelman School of Pharmacy…Opens in new window

This work was supported by Lai’sPackard FellowshipOpens in new windowandNSF Career AwardOpens in new window, the National Institutes of Health, theEshelman Institute of InnovationOpens in new window, graduate fellowships from the NSF and PhARMA Foundation, and the National Science Foundation.

This is story number 89 in the Carolina Stories 225th Anniversary Edition magazine.
 

UNC Eshelman School of Pharmacy Funding Priorities

    Readers Also Viewed...

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers